Naturally-acquired immunity to Neisseria meningitidis group A

This publication has 28 references indexed in Scilit:

• Opportunities for Control of Meningococcal Disease in the United States
  Annual Review of Medicine, 2004
• Preparation and Characterization of Group A Meningococcal Capsular Polysaccharide Conjugates and Evaluation of Their Immunogenicity in Mice
  Infection and Immunity, 2003
• Disparity in Functional Activity between Serum Anticapsular Antibodies Induced in Adults by Immunization with an Investigational Group A and CNeisseria meningitidis-Diphtheria Toxoid Conjugate Vaccine and by a Polysaccharide Vaccine
  Infection and Immunity, 2003
• Age-Related Disparity in Functional Activities of Human Group C Serum Anticapsular Antibodies Elicited by Meningococcal Polysaccharide Vaccine
  Infection and Immunity, 2003
• Genotype‐Specific Carriage ofNeisseria meningitidisin Georgia Counties with Hyper‐ and Hyposporadic Rates of Meningococcal Disease
  The Journal of Infectious Diseases, 2002
• Molecular Epidemiology of Serogroup A Meningitis in Moscow, 1969 to 1997
  Emerging Infectious Diseases, 2001
• Meningococcal meningitis in Africa
  Transactions of the Royal Society of Tropical Medicine and Hygiene, 1999
• Total and functional antibody response to a quadrivalent meningococcal polysaccharide vaccine among children
  The Journal of Pediatrics, 1996
• Escherichia coli K51 and K93 capsular polysaccharides are crossreactive with the group A capsular polysaccharide of Neisseria meningitidis. Immunochemical, biological, and epidemiological studies.
  The Journal of Experimental Medicine, 1985
• Clinical Efficacy of Meningococcus Group A Capsular Polysaccharide Vaccine in Children Three Months to Five Years of Age
  New England Journal of Medicine, 1977